Global Gonorrhea Therapeutics Market Insights, Forecast to 2029

Publisher Name :
Date: 14-Aug-2023
No. of pages: 89
Inquire Before Buying

Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospects.

Market Analysis and Insights: Global Gonorrhea Therapeutics Market

The global Gonorrhea Therapeutics market is projected to grow from US$ 1128.3 million in 2023 to US$ 1427.7 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period.

The latest trend gaining momentum in the market is Advent of vaccine for prevention of gonorrhea. Gonorrhea is a major public health concern globally. It is considerably affecting the reproductive health of people and increasing the spread of human immunodeficiency virus (HIV). The currently available treatment regimen is unsuccessful in controlling the spread of Neisseria gonorrhoeae due to the rapid emergence of the antibiotic-resistant strains of this bacterium. Therefore, the prevention of the disease seems to be a more appropriate approach for controlling the spread of Neisseria gonorrhoeae.

Report Includes

This report presents an overview of global market for Gonorrhea Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Gonorrhea Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gonorrhea Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gonorrhea Therapeutics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Gonorrhea Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Gonorrhea Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bharat Pharmaceuticals, GlaxoSmithKline, Merck, Pfizer, Alopexx Pharmaceuticals, AstraZeneca, Debiopharm Group and Melinta Therapeutics, etc.

By Company

- Bharat Pharmaceuticals

- GlaxoSmithKline

- Merck

- Pfizer

- Alopexx Pharmaceuticals

- AstraZeneca

- Debiopharm Group

- Melinta Therapeutics

Segment by Type

- Monotherapy

- Dual Therapy

Segment by Application

- Clinics

- Hospitals

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Gonorrhea Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gonorrhea Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gonorrhea Therapeutics revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Gonorrhea Therapeutics Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gonorrhea Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monotherapy
1.2.3 Dual Therapy
1.3 Market by Application
1.3.1 Global Gonorrhea Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gonorrhea Therapeutics Market Perspective (2018-2029)
2.2 Global Gonorrhea Therapeutics Growth Trends by Region
2.2.1 Gonorrhea Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gonorrhea Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Gonorrhea Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Gonorrhea Therapeutics Market Dynamics
2.3.1 Gonorrhea Therapeutics Industry Trends
2.3.2 Gonorrhea Therapeutics Market Drivers
2.3.3 Gonorrhea Therapeutics Market Challenges
2.3.4 Gonorrhea Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gonorrhea Therapeutics by Players
3.1.1 Global Gonorrhea Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Gonorrhea Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Gonorrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gonorrhea Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Gonorrhea Therapeutics Market Concentration Ratio
3.4.1 Global Gonorrhea Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gonorrhea Therapeutics Revenue in 2022
3.5 Global Key Players of Gonorrhea Therapeutics Head office and Area Served
3.6 Global Key Players of Gonorrhea Therapeutics, Product and Application
3.7 Global Key Players of Gonorrhea Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gonorrhea Therapeutics Breakdown Data by Type
4.1 Global Gonorrhea Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Gonorrhea Therapeutics Forecasted Market Size by Type (2024-2029)
5 Gonorrhea Therapeutics Breakdown Data by Application
5.1 Global Gonorrhea Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Gonorrhea Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gonorrhea Therapeutics Market Size (2018-2029)
6.2 North America Gonorrhea Therapeutics Market Size by Type
6.2.1 North America Gonorrhea Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Gonorrhea Therapeutics Market Size by Type (2024-2029)
6.2.3 North America Gonorrhea Therapeutics Market Share by Type (2018-2029)
6.3 North America Gonorrhea Therapeutics Market Size by Application
6.3.1 North America Gonorrhea Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Gonorrhea Therapeutics Market Size by Application (2024-2029)
6.3.3 North America Gonorrhea Therapeutics Market Share by Application (2018-2029)
6.4 North America Gonorrhea Therapeutics Market Size by Country
6.4.1 North America Gonorrhea Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Gonorrhea Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Gonorrhea Therapeutics Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Gonorrhea Therapeutics Market Size (2018-2029)
7.2 Europe Gonorrhea Therapeutics Market Size by Type
7.2.1 Europe Gonorrhea Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Gonorrhea Therapeutics Market Size by Type (2024-2029)
7.2.3 Europe Gonorrhea Therapeutics Market Share by Type (2018-2029)
7.3 Europe Gonorrhea Therapeutics Market Size by Application
7.3.1 Europe Gonorrhea Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Gonorrhea Therapeutics Market Size by Application (2024-2029)
7.3.3 Europe Gonorrhea Therapeutics Market Share by Application (2018-2029)
7.4 Europe Gonorrhea Therapeutics Market Size by Country
7.4.1 Europe Gonorrhea Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Gonorrhea Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Gonorrhea Therapeutics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gonorrhea Therapeutics Market Size (2018-2029)
8.2 China Gonorrhea Therapeutics Market Size by Type
8.2.1 China Gonorrhea Therapeutics Market Size by Type (2018-2023)
8.2.2 China Gonorrhea Therapeutics Market Size by Type (2024-2029)
8.2.3 China Gonorrhea Therapeutics Market Share by Type (2018-2029)
8.3 China Gonorrhea Therapeutics Market Size by Application
8.3.1 China Gonorrhea Therapeutics Market Size by Application (2018-2023)
8.3.2 China Gonorrhea Therapeutics Market Size by Application (2024-2029)
8.3.3 China Gonorrhea Therapeutics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Gonorrhea Therapeutics Market Size (2018-2029)
9.2 Asia Gonorrhea Therapeutics Market Size by Type
9.2.1 Asia Gonorrhea Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Gonorrhea Therapeutics Market Size by Type (2024-2029)
9.2.3 Asia Gonorrhea Therapeutics Market Share by Type (2018-2029)
9.3 Asia Gonorrhea Therapeutics Market Size by Application
9.3.1 Asia Gonorrhea Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Gonorrhea Therapeutics Market Size by Application (2024-2029)
9.3.3 Asia Gonorrhea Therapeutics Market Share by Application (2018-2029)
9.4 Asia Gonorrhea Therapeutics Market Size by Region
9.4.1 Asia Gonorrhea Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Gonorrhea Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Gonorrhea Therapeutics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bharat Pharmaceuticals
11.1.1 Bharat Pharmaceuticals Company Details
11.1.2 Bharat Pharmaceuticals Business Overview
11.1.3 Bharat Pharmaceuticals Gonorrhea Therapeutics Introduction
11.1.4 Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.1.5 Bharat Pharmaceuticals Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Gonorrhea Therapeutics Introduction
11.2.4 GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.2.5 GlaxoSmithKline Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Gonorrhea Therapeutics Introduction
11.3.4 Merck Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.3.5 Merck Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Gonorrhea Therapeutics Introduction
11.4.4 Pfizer Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.4.5 Pfizer Recent Developments
11.5 Alopexx Pharmaceuticals
11.5.1 Alopexx Pharmaceuticals Company Details
11.5.2 Alopexx Pharmaceuticals Business Overview
11.5.3 Alopexx Pharmaceuticals Gonorrhea Therapeutics Introduction
11.5.4 Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.5.5 Alopexx Pharmaceuticals Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Gonorrhea Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.6.5 AstraZeneca Recent Developments
11.7 Debiopharm Group
11.7.1 Debiopharm Group Company Details
11.7.2 Debiopharm Group Business Overview
11.7.3 Debiopharm Group Gonorrhea Therapeutics Introduction
11.7.4 Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.7.5 Debiopharm Group Recent Developments
11.8 Melinta Therapeutics
11.8.1 Melinta Therapeutics Company Details
11.8.2 Melinta Therapeutics Business Overview
11.8.3 Melinta Therapeutics Gonorrhea Therapeutics Introduction
11.8.4 Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2018-2023)
11.8.5 Melinta Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Gonorrhea Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Monotherapy
Table 3. Key Players of Dual Therapy
Table 4. Global Gonorrhea Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Gonorrhea Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gonorrhea Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Gonorrhea Therapeutics Market Share by Region (2018-2023)
Table 8. Global Gonorrhea Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gonorrhea Therapeutics Market Share by Region (2024-2029)
Table 10. Gonorrhea Therapeutics Market Trends
Table 11. Gonorrhea Therapeutics Market Drivers
Table 12. Gonorrhea Therapeutics Market Challenges
Table 13. Gonorrhea Therapeutics Market Restraints
Table 14. Global Gonorrhea Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Gonorrhea Therapeutics Revenue Share by Players (2018-2023)
Table 16. Global Top Gonorrhea Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonorrhea Therapeutics as of 2022)
Table 17. Global Gonorrhea Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Gonorrhea Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Gonorrhea Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Gonorrhea Therapeutics, Product and Application
Table 21. Global Key Players of Gonorrhea Therapeutics, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gonorrhea Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Gonorrhea Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Gonorrhea Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gonorrhea Therapeutics Revenue Market Share by Type (2024-2029)
Table 27. Global Gonorrhea Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Gonorrhea Therapeutics Revenue Share by Application (2018-2023)
Table 29. Global Gonorrhea Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gonorrhea Therapeutics Revenue Share by Application (2024-2029)
Table 31. North America Gonorrhea Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Gonorrhea Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Gonorrhea Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Gonorrhea Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Gonorrhea Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Gonorrhea Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Gonorrhea Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Gonorrhea Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Gonorrhea Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Gonorrhea Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Gonorrhea Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Gonorrhea Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Gonorrhea Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Gonorrhea Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Gonorrhea Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Gonorrhea Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Gonorrhea Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Gonorrhea Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Gonorrhea Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Gonorrhea Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Gonorrhea Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Gonorrhea Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Gonorrhea Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Gonorrhea Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Gonorrhea Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gonorrhea Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 63. Bharat Pharmaceuticals Company Details
Table 64. Bharat Pharmaceuticals Business Overview
Table 65. Bharat Pharmaceuticals Gonorrhea Therapeutics Product
Table 66. Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 67. Bharat Pharmaceuticals Recent Developments
Table 68. GlaxoSmithKline Company Details
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Gonorrhea Therapeutics Product
Table 71. GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 72. GlaxoSmithKline Recent Developments
Table 73. Merck Company Details
Table 74. Merck Business Overview
Table 75. Merck Gonorrhea Therapeutics Product
Table 76. Merck Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 77. Merck Recent Developments
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Gonorrhea Therapeutics Product
Table 81. Pfizer Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 82. Pfizer Recent Developments
Table 83. Alopexx Pharmaceuticals Company Details
Table 84. Alopexx Pharmaceuticals Business Overview
Table 85. Alopexx Pharmaceuticals Gonorrhea Therapeutics Product
Table 86. Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 87. Alopexx Pharmaceuticals Recent Developments
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Gonorrhea Therapeutics Product
Table 91. AstraZeneca Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 92. AstraZeneca Recent Developments
Table 93. Debiopharm Group Company Details
Table 94. Debiopharm Group Business Overview
Table 95. Debiopharm Group Gonorrhea Therapeutics Product
Table 96. Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 97. Debiopharm Group Recent Developments
Table 98. Melinta Therapeutics Company Details
Table 99. Melinta Therapeutics Business Overview
Table 100. Melinta Therapeutics Gonorrhea Therapeutics Product
Table 101. Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2018-2023) & (US$ Million)
Table 102. Melinta Therapeutics Recent Developments
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gonorrhea Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Gonorrhea Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Monotherapy Features
Figure 4. Dual Therapy Features
Figure 5. Global Gonorrhea Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Gonorrhea Therapeutics Market Share by Application: 2022 VS 2029
Figure 7. Clinics Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Others Case Studies
Figure 10. Gonorrhea Therapeutics Report Years Considered
Figure 11. Global Gonorrhea Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Gonorrhea Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gonorrhea Therapeutics Market Share by Region: 2022 VS 2029
Figure 14. Global Gonorrhea Therapeutics Market Share by Players in 2022
Figure 15. Global Top Gonorrhea Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonorrhea Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gonorrhea Therapeutics Revenue in 2022
Figure 17. North America Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Gonorrhea Therapeutics Market Share by Type (2018-2029)
Figure 19. North America Gonorrhea Therapeutics Market Share by Application (2018-2029)
Figure 20. North America Gonorrhea Therapeutics Market Share by Country (2018-2029)
Figure 21. United States Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Gonorrhea Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Gonorrhea Therapeutics Market Share by Type (2018-2029)
Figure 25. Europe Gonorrhea Therapeutics Market Share by Application (2018-2029)
Figure 26. Europe Gonorrhea Therapeutics Market Share by Country (2018-2029)
Figure 27. Germany Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Gonorrhea Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Gonorrhea Therapeutics Market Share by Type (2018-2029)
Figure 35. China Gonorrhea Therapeutics Market Share by Application (2018-2029)
Figure 36. Asia Gonorrhea Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Gonorrhea Therapeutics Market Share by Type (2018-2029)
Figure 38. Asia Gonorrhea Therapeutics Market Share by Application (2018-2029)
Figure 39. Asia Gonorrhea Therapeutics Market Share by Region (2018-2029)
Figure 40. Japan Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Gonorrhea Therapeutics Market Share by Country (2018-2029)
Figure 50. Brazil Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Gonorrhea Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Bharat Pharmaceuticals Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 58. Merck Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 59. Pfizer Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 60. Alopexx Pharmaceuticals Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 61. AstraZeneca Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 62. Debiopharm Group Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 63. Melinta Therapeutics Revenue Growth Rate in Gonorrhea Therapeutics Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
  • Global Sexually Transmitted Diseases Testing Professional Survey Report 2023, Forecast to 2028
    Published: 22-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Sexually Transmitted Diseases Testing Market Research Report 2023, Forecast to 2028
    Published: 22-Dec-2023        Price: US 2680 Onwards        Pages: 130
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Sexually Transmitted Disease (STD) Testing Market Status and Outlook 2023-2028
    Published: 23-Nov-2023        Price: US 3160 Onwards        Pages: 102
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Sexually Transmitted Disease (Std) Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Oct-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Sexually Transmitted Disease (Std) Testing market: According to our latest research, the global Sexually Transmitted Disease (Std) Testing market looks promising in the next 5 years. As of 2022, the global Sexually Transmitted Disease (Std) Testing market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and pr......
  • Global Gonorrhea Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Oct-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Gonorrhea Therapeutics market: According to our latest research, the global Gonorrhea Therapeutics market looks promising in the next 5 years. As of 2022, the global Gonorrhea Therapeutics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Gonorrhea is a sexually transmitted disease (STD) caused by the bacterium Neisseria gonorrhea. It tends to infect the urethra......
  • Global Gonorrhea Therapeutics Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 89
    Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospec......
  • Global Sexually Transmitted Disease (STD) Testing Market Insights, Forecast to 2029
    Published: 01-Jun-2023        Price: US 4900 Onwards        Pages: 92
    Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD). Market Analysis and Insights: Global Sexually Transmitted Disease (STD) Testing Market The global Sexually Transmitted Disease (STD) Testing market is projected to grow from US$ 225.3 million in 2023 to US$ 338.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period. The need for tests that eliminate ......
  • Global Sexually Transmitted Disease (STD) Testing Market Research Report 2023
    Published: 05-May-2023        Price: US 2900 Onwards        Pages: 89
    Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD). Highlights The global Sexually Transmitted Disease (STD) Testing market was valued at US$ 225.3 million in 2022 and is anticipated to reach US$ 338.1 million by 2029, witnessing a CAGR of 7.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. The need ......
  • Global Gonorrhea Therapeutics Market Status and Outlook 2023-2028
    Published: 24-Apr-2023        Price: US 3160 Onwards        Pages: 104
    Neisseria gonorrhoeae infection can manifest as a variety of symptoms, which can affect the genitourinary system, anorectum, pharynx, and conjunctival area. Severe cases can lead to disseminated gonococcal infection, endocarditis and meningitis; in women, it is pelvic inflammatory disease (PID). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs